We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > hematopoietic stem cell

News List

FDA Approves Orencia in Combination with a Calcineurin Inhibitor and Methotrexate for the Prevention of Graft Versus Host Disease AmericanPharmaceuticalReview
December 17, 2021
Bristol Myers Squibb announced that Orencia® (abatacept) was approved by the FDA for the prophylaxis, or prevention, of acute graft versus host disease (aGvHD), in combination with a calcineurin inhibitor (CNI) and methotrexate (MTX), in adults and...
BioLineRx Announces Submission of Phase 3 Registrational Study for BL-8040 pharmaceutical-technology
August 23, 2017
BioLineRx announced the filing of regulatory submissions required to commence a randomized, controlled Phase 3 registrational trial of BL-8040 for the mobilization of hematopoietic stem cells for autologous transplantation in patients with multiple myelom